BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 3766088)

  • 21. [Thrombotic thrombopenic purpura associated with Hodgkin's disease].
    Dumoulin-Lagrange M; Tulliez M; Diebold J; Samama M; Bousser J
    Nouv Rev Fr Hematol (1978); 1983; 25(4):275-6. PubMed ID: 6684765
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between immune thrombocytopenic purpura and chronic lymphocytic leukemia in a patient carrier of anti-hepatitis C virus antibodies.
    Numeroso F; Baroni MC; Delsignore R
    Ann Ital Med Int; 2005; 20(3):197-202. PubMed ID: 16250187
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune thrombocytopenic purpura in a child with Hodgkin's disease.
    Berberoğlu S; Sarialioğlu F; Akyüz C; Kutluk T; Büyükpamukçu M
    Turk J Pediatr; 1995; 37(3):289-92. PubMed ID: 7502371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoimmune disorders complicating adolescent Hodgkin's disease.
    Kedar A; Khan AB; Mattern JQ; Fisher J; Thomas PR; Freeman AI
    Cancer; 1979 Jul; 44(1):112-6. PubMed ID: 572259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Corticosteroid responsive immune thrombocytopenia in Hodgkin's disease.
    Sonnenblick M; Kramer R; Hershko C
    Oncology; 1986; 43(6):349-53. PubMed ID: 3808566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leukopenia, thrombocytopenia, and acute autoimmune hemolytic anemia associated with an unusual (type 2/4) Hodgkin's disease: case report.
    Costello RT; Xerri L; Bouabdallah R; Gastaut JA; Sainty D
    Am J Hematol; 1996 Aug; 52(4):333-4. PubMed ID: 8701964
    [No Abstract]   [Full Text] [Related]  

  • 27. [Autoimmune thrombocytopenic purpura in malignant lymphoma. Report of 2 cases and review of the literature].
    Obrist R; Ludwig C; Klüppelberg J; Obrecht JP
    Schweiz Med Wochenschr; 1985 Sep; 115(36):1236-41. PubMed ID: 4048919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
    Schweizer C; Reu FJ; Ho AD; Hensel M
    Ann Hematol; 2007 Oct; 86(10):711-7. PubMed ID: 17622529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitoxantrone, vinblastine, and lomustine (CCNU) (MVC): a highly active regimen for advanced and poor-prognosis Hodgkin's disease.
    Wiernik PH; Dutcher JP; Einzig AI; Sparano J; Frank M; Friedenberg W
    Cancer J Sci Am; 1998; 4(4):254-60. PubMed ID: 9689984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia.
    Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R
    Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Autoimmune thrombopenia and Hodgkin's disease: proof of autoimmunity by elution of antiplatelet antibodies from the platelet surface].
    Maheu M
    Union Med Can; 1984 Nov; 113(11):962-5. PubMed ID: 6393517
    [No Abstract]   [Full Text] [Related]  

  • 32. Cavernous sinus syndrome in Hodgkin's disease.
    Kasner SE; Galetta SL; Vaughn DJ
    J Neuroophthalmol; 1996 Sep; 16(3):204-7. PubMed ID: 8865016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute lymphoblastic leukemia following Hodgkin's disease.
    Saleem A; Johnston RL
    Ann Clin Lab Sci; 1980; 10(2):100-4. PubMed ID: 6930197
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoimmune thrombocytopenia in non-Hodgkin's lymphomas.
    Hauswirth AW; Skrabs C; Schützinger C; Raderer M; Chott A; Valent P; Lechner K; Jäger U
    Haematologica; 2008 Mar; 93(3):447-50. PubMed ID: 18287133
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coexistence of Hodgkin's disease and giant lymph node hyperplasia of the plasma-cell type (Castleman's disease).
    Abdel-Reheim FA; Koss W; Rappaport ES; Arber DA
    Arch Pathol Lab Med; 1996 Jan; 120(1):91-6. PubMed ID: 8554455
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-dose ifosfamide in combination with etoposide and epirubicin (IVE) in the treatment of relapsed/refractory Hodgkin's disease and non-Hodgkin's lymphoma: a report on toxicity and efficacy.
    Proctor SJ; Taylor PR; Angus B; Wood K; Lennard AL; Lucraft H; Carey PJ; Stark A; Iqbal A; Haynes A; Russel N; Leonard RC; Culligan D; Conn J; Jackson GH
    Eur J Haematol Suppl; 2001 Jul; 64():28-32. PubMed ID: 11486397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombocytopenic purpura as the sole manifestation of a recurrence of Hodgkin's disease.
    Hamilton PJ; Dawson AA
    J Clin Pathol; 1973 Jan; 26(1):70-2. PubMed ID: 4735082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eosinophilic meningitis in Hodgkin's disease. Report of a case and review of the literature.
    Hollister D; Clements M; Coleman M; Petito F
    Arch Intern Med; 1983 Mar; 143(3):590-2. PubMed ID: 6338855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.
    Enrici RM; Anselmo AP; Donato V; Falchetto Osti M; Santoro M; Tombolini V; Mandelli F
    Haematologica; 1999 Oct; 84(10):917-23. PubMed ID: 10509040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune Thrombocytopenia Secondary to Hodgkin's Lymphoma in Children.
    Tanous O; Dujovny T; Hertzel G; Koren A; Levin C
    Isr Med Assoc J; 2020 Apr; 22(4):224-226. PubMed ID: 32286024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.